$ELOX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Eloxx Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eloxx Pharmaceuticals, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.45 | 8,800 | 3,960 | 36,000 | 27.2 K to 36 K (+32.35 %) |
Feb 24 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.44 | 6,200 | 2,697 | 27,200 | 21 K to 27.2 K (+29.52 %) |
Feb 24 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.47 | 12,766 | 6,000 | 262,766 | |
Feb 24 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.42 | 3,800 | 1,595 | 23,000 | 19.2 K to 23 K (+19.79 %) |
Feb 24 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.40 | 1,200 | 480 | 23,000 | 21.8 K to 23 K (+5.50 %) |
Feb 24 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.52 | 23,404 | 12,170 | 337,988 | |
Feb 24 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.47 | 22,340 | 10,500 | 276,090 | |
Feb 24 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.47 | 28,191 | 13,250 | 726,525 | |
Feb 24 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.47 | 21,277 | 10,000 | 129,193 | |
Feb 24 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.47 | 7,092 | 3,333 | 7,092 | |
Dec 31 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 600 | 390 | 289,480 | 290.1 K to 289.5 K (-0.21 %) |
Dec 31 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 900 | 585 | 289,480 | 290.4 K to 289.5 K (-0.31 %) |
Dec 29 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 3,400 | 2,210 | 290,980 | 294.4 K to 291 K (-1.15 %) |
Dec 29 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 100 | 65 | 290,980 | 291.1 K to 291 K (-0.03 %) |
Dec 23 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 100 | 65 | 294,480 | 294.6 K to 294.5 K (-0.03 %) |
Dec 19 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.65 | 6,600 | 4,290 | 294,580 | 301.2 K to 294.6 K (-2.19 %) |
Dec 17 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.70 | 2,000 | 1,400 | 2,040,021 | 2 M to 2 M (+0.10 %) |
Dec 17 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.74 | 2,000 | 1,480 | 2,040,021 | 2 M to 2 M (+0.10 %) |
Dec 17 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.73 | 5,700 | 4,142 | 301,180 | 306.9 K to 301.2 K (-1.86 %) |
Dec 17 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Sell | S | 0.69 | 7,600 | 5,260 | 301,180 | 308.8 K to 301.2 K (-2.46 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Sell | S | 0.67 | 5,400 | 3,594 | 102,275 | 107.7 K to 102.3 K (-5.02 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Sell | S | 0.60 | 11,600 | 6,960 | 102,275 | 113.9 K to 102.3 K (-10.19 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.70 | 3,000 | 2,100 | 2,036,021 | 2 M to 2 M (+0.15 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.61 | 2,900 | 1,769 | 2,036,021 | 2 M to 2 M (+0.14 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.60 | 100 | 60 | 2,036,021 | 2 M to 2 M (0.00 %) |
Dec 16 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.60 | 4,000 | 2,400 | 2,036,021 | 2 M to 2 M (+0.20 %) |
Nov 21 2008 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.60 | 10,000 | 6,000 | 250,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.60 | 70,000 | 42,000 | 240,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.66 | 50,000 | 33,000 | 300,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.66 | 14,584 | 9,625 | 314,584 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 0.60 | 48,000 | 28,800 | 570,676 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.60 | 17,916 | 10,750 | 107,916 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.60 | 40,000 | 24,000 | 90,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.60 | 18,334 | 11,000 | 698,334 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.60 | 80,000 | 48,000 | 680,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.60 | 10,000 | 6,000 | 280,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.60 | 70,000 | 42,000 | 270,000 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.60 | 80,000 | 48,000 | 511,924 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Grant | A | 0.60 | 66,000 | 39,600 | 314,480 | 248.5 K to 314.5 K (+26.56 %) |
Nov 21 2008 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Grant | A | 0.60 | 42,000 | 25,200 | 155,560 | 113.6 K to 155.6 K (+36.98 %) |
Nov 21 2008 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Grant | A | 0.60 | 28,000 | 16,800 | 119,275 | 91.3 K to 119.3 K (+30.68 %) |
Nov 21 2008 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.60 | 13,750 | 8,250 | 253,750 | |
Nov 21 2008 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.60 | 40,000 | 24,000 | 240,000 | |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.05 | 16 | 17 | 2,026,021 | 2 M to 2 M (0.00 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.99 | 325 | 322 | 2,026,021 | 2 M to 2 M (+0.02 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.96 | 1,500 | 1,440 | 2,026,021 | 2 M to 2 M (+0.07 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.95 | 1,000 | 950 | 2,026,021 | 2 M to 2 M (+0.05 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.90 | 2,659 | 2,393 | 2,026,021 | 2 M to 2 M (+0.13 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.89 | 399 | 355 | 2,026,021 | 2 M to 2 M (+0.02 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 9,201 | 8,097 | 2,026,021 | 2 M to 2 M (+0.46 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 2,800 | 2,464 | 2,010,921 | 2 M to 2 M (+0.14 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.86 | 7,000 | 6,020 | 1,998,021 | 2 M to 2 M (+0.35 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 7,900 | 6,952 | 1,998,021 | 2 M to 2 M (+0.40 %) |
Mar 12 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 100 | 84 | 2,008,121 | 2 M to 2 M (0.00 %) |
Mar 12 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 10,000 | 8,800 | 2,008,121 | 2 M to 2 M (+0.50 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 550 | 462 | 1,983,121 | 2 M to 2 M (+0.03 %) |
Mar 07 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.86 | 9,800 | 8,428 | 1,982,571 | 2 M to 2 M (+0.50 %) |
Mar 07 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.85 | 10,000 | 8,500 | 1,982,571 | 2 M to 2 M (+0.51 %) |
Mar 06 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.81 | 500 | 405 | 1,962,771 | 2 M to 2 M (+0.03 %) |
Mar 06 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 11,900 | 9,996 | 1,962,771 | 2 M to 2 M (+0.61 %) |
Mar 03 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 900 | 711 | 1,950,371 | 1.9 M to 2 M (+0.05 %) |
Feb 29 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 100 | 78 | 1,949,471 | 1.9 M to 1.9 M (+0.01 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 5,000 | 3,900 | 1,949,371 | 1.9 M to 1.9 M (+0.26 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.77 | 200 | 154 | 1,949,371 | 1.9 M to 1.9 M (+0.01 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 9,000 | 6,750 | 1,949,371 | 1.9 M to 1.9 M (+0.46 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.74 | 1,000 | 740 | 1,949,371 | 1.9 M to 1.9 M (+0.05 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.80 | 100 | 80 | 1,934,171 | 1.9 M to 1.9 M (+0.01 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 2,100 | 1,659 | 1,934,171 | 1.9 M to 1.9 M (+0.11 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 2,800 | 2,184 | 1,934,171 | 1.9 M to 1.9 M (+0.14 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.76 | 5,000 | 3,800 | 1,934,171 | 1.9 M to 1.9 M (+0.26 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 17,000 | 13,430 | 1,924,171 | 1.9 M to 1.9 M (+0.89 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 5,900 | 4,602 | 1,924,171 | 1.9 M to 1.9 M (+0.31 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.77 | 400 | 308 | 1,924,171 | 1.9 M to 1.9 M (+0.02 %) |
Feb 22 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.80 | 20,000 | 16,000 | 1,900,871 | 1.9 M to 1.9 M (+1.06 %) |
Feb 22 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 18,300 | 13,725 | 1,900,871 | 1.9 M to 1.9 M (+0.97 %) |
Feb 20 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 6,450 | 4,838 | 1,862,571 | 1.9 M to 1.9 M (+0.35 %) |
Feb 20 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.70 | 8,550 | 5,985 | 1,862,571 | 1.9 M to 1.9 M (+0.46 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Grant | A | 0.99 | 125,000 | 123,750 | 248,480 | 123.5 K to 248.5 K (+101.23 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Grant | A | 0.99 | 50,255 | 49,752 | 123,480 | 73.2 K to 123.5 K (+68.63 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Grant | A | 0.99 | 50,000 | 49,500 | 113,560 | 63.6 K to 113.6 K (+78.67 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Grant | A | 0.99 | 25,200 | 24,948 | 63,560 | 38.4 K to 63.6 K (+65.69 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.99 | 300,000 | 297,000 | 431,924 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.99 | 71,924 | 71,205 | 131,924 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 0.99 | 250,000 | 247,500 | 522,676 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 0.99 | 52,676 | 52,149 | 272,676 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.99 | 40,000 | 39,600 | 50,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Grant | A | 0.99 | 50,000 | 49,500 | 91,275 | 41.3 K to 91.3 K (+121.14 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Grant | A | 0.99 | 37,275 | 36,902 | 41,275 | 4 K to 41.3 K (+931.88 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.99 | 80,000 | 79,200 | 200,000 | |
Dec 13 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.94 | 146,000 | 136,598 | 1,782,571 | 1.6 M to 1.8 M (+8.92 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.99 | 80,000 | 79,200 | 600,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.99 | 20,000 | 19,800 | 200,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.09 | 50,000 | 54,500 | 250,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.99 | 80,000 | 79,200 | 170,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.91 | 15,000 | 13,601 | 1,847,571 | 1.8 M to 1.8 M (+0.82 %) |
Dec 13 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.95 | 50,000 | 47,500 | 1,832,571 | 1.8 M to 1.8 M (+2.80 %) |
Dec 12 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 50,000 | 38,870 | 1,636,571 | 1.6 M to 1.6 M (+3.15 %) |
Dec 11 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.54 | 54,000 | 28,928 | 1,586,571 | 1.5 M to 1.6 M (+3.52 %) |
Mar 22 2007 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 1.05 | 10,000 | 10,500 | 10,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Option Exercise | A | 1.08 | 40,000 | 43,200 | 625,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Option Exercise | A | 1.08 | 25,000 | 27,000 | 185,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 1.08 | 25,000 | 27,000 | 220,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Option Exercise | A | 1.08 | 25,000 | 27,000 | 157,500 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 1.08 | 25,000 | 27,000 | 60,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 1.08 | 40,000 | 43,200 | 520,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 200,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 90,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 120,000 | |
Dec 18 2006 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 1.08 | 20,000 | 21,600 | 180,000 | |
Nov 30 2006 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 1.15 | 1,000 | 1,150 | 211,771 | 210.8 K to 211.8 K (+0.47 %) |
Nov 30 2006 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 1.16 | 9,000 | 10,440 | 210,771 | 201.8 K to 210.8 K (+4.46 %) |
Oct 13 2006 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 1.18 | 132,450 | 156,291 | 132,450 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Grant | A | 1.07 | 264,901 | 283,444 | 264,901 | 0 to 264.9 K |
Oct 13 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.18 | 441,501 | 520,971 | 635,430 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Grant | A | 1.07 | 883,002 | 944,812 | 1,532,571 | 649.6 K to 1.5 M (+135.94 %) |
Oct 13 2006 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 1.18 | 46,729 | 55,140 | 62,552 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Grant | A | 1.07 | 93,458 | 100,000 | 201,771 | 108.3 K to 201.8 K (+86.29 %) |
Oct 13 2006 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Option Exercise | A | 1.18 | 33,113 | 39,073 | 33,113 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Grant | A | 1.07 | 66,225 | 70,861 | 73,225 | 7 K to 73.2 K (+946.07 %) |
Oct 13 2006 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 1.18 | 5,000 | 5,900 | 5,000 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Grant | A | 1.07 | 10,000 | 10,700 | 18,000 | 8 K to 18 K (+125.00 %) |
Oct 13 2006 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 1.18 | 5,000 | 5,900 | 5,000 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Grant | A | 1.07 | 10,000 | 10,700 | 21,000 | 11 K to 21 K (+90.91 %) |
Mar 20 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.50 | 40,000 | 60,000 | 649,569 | 609.6 K to 649.6 K (+6.56 %) |
Dec 16 2005 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Option Exercise | A | 1.40 | 25,000 | 35,000 | 132,500 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Option Exercise | A | 1.40 | 40,000 | 56,000 | 585,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 1.40 | 25,000 | 35,000 | 35,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Option Exercise | A | 1.40 | 20,000 | 28,000 | 160,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 1.40 | 20,000 | 28,000 | 195,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 1.40 | 40,000 | 56,000 | 495,823 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 60,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 363,929 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 90,000 | |
Dec 16 2005 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 249,053 | |
Nov 30 2005 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.49 | 6,500 | 9,685 | 609,569 | 603.1 K to 609.6 K (+1.08 %) |
Nov 30 2005 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.49 | 23,500 | 35,015 | 609,569 | 586.1 K to 609.6 K (+4.01 %) |
Dec 15 2005 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 1.40 | 10,000 | 14,000 | 108,313 | 98.3 K to 108.3 K (+10.17 %) |
Nov 30 2005 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 1.59 | 5,000 | 7,950 | 8,000 | 3 K to 8 K (+166.67 %) |
Nov 23 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 1.31 | 1,000 | 1,310 | 11,000 | 10 K to 11 K (+10.00 %) |
Nov 22 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 1.27 | 1,000 | 1,270 | 10,000 | 9 K to 10 K (+11.11 %) |
Nov 22 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 1.31 | 1,000 | 1,310 | 10,000 | 9 K to 10 K (+11.11 %) |
Nov 22 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 1.34 | 1,000 | 1,340 | 10,000 | 9 K to 10 K (+11.11 %) |
Jun 08 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 2.24 | 2,000 | 4,480 | 54,500 | 52.5 K to 54.5 K (+3.81 %) |
May 19 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 2.22 | 3,000 | 6,660 | 52,500 | 49.5 K to 52.5 K (+6.06 %) |
May 19 2005 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | President & CEO | Buy | P | 2.25 | 3,500 | 7,875 | 502,000 | 498.5 K to 502 K (+0.70 %) |
May 19 2005 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Buy | P | 2.26 | 2,000 | 4,520 | 82,335 | 80.3 K to 82.3 K (+2.49 %) |
May 19 2005 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 2.19 | 3,000 | 6,570 | 20,500 | 17.5 K to 20.5 K (+17.14 %) |
Feb 28 2005 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 2.94 | 2,000 | 5,880 | 2,000 | 0 to 2 K |
Dec 20 2004 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 3.45 | 20,000 | 69,000 | 229,053 | |
Dec 20 2004 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 3.45 | 30,000 | 103,500 | 455,823 |